» Articles » PMID: 2987704

Detection and Sequence of Mutations in the Factor VIII Gene of Haemophiliacs

Overview
Journal Nature
Specialty Science
Date 1985 May 5
PMID 2987704
Citations 60
Authors
Affiliations
Soon will be listed here.
Abstract

The most common inherited bleeding disorder in man, haemophilia A, is caused by defect in factor VIII, a component in the blood coagulation pathway. The X-chromosome-linked disease almost certainly stems from a heterogeneous collection of genetic lesions. Because, without proper treatment, haemophilia can be a fatal disease, new mutations are necessary to account for its constant frequency in the population. In addition, haemophilia A displays a wide range of severity, and some 15% of haemophiliacs generate high levels of antibodies against factor VIII ('inhibitor patients'). The present work elucidates the molecular genetic basis of haemophilia in some individuals. Using the recently cloned factor VIII gene as a probe, we have identified two different nonsense point mutations in the factor VIII gene of haemophiliacs, as well as two different partial deletions of the gene. Our survey of 92 haemophiliacs indicates no firm correlation between antibody (inhibitor) production and gross gene defects.

Citing Articles

Pro-haemostatic effect of DDAVP is partially derived through non-classical (CD14 /CD16 ) monocytes residing the spleen.

Salarilak L, Pirdel Z, Dinmohammadi H, Rokni-Zadeh H, Lavendhomme R, Karimi M J Cell Mol Med. 2022; 27(1):30-35.

PMID: 36479816 PMC: 9806299. DOI: 10.1111/jcmm.17606.


Novel copy number variations within SYCE1 caused meiotic arrest and non-obstructive azoospermia.

Huang Y, Tian R, Xu J, Ji Z, Zhang Y, Zhao L BMC Med Genomics. 2022; 15(1):137.

PMID: 35718780 PMC: 9208180. DOI: 10.1186/s12920-022-01288-8.


DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects.

Pos O, Radvanszky J, Buglyo G, Pos Z, Rusnakova D, Nagy B Biomed J. 2021; 44(5):548-559.

PMID: 34649833 PMC: 8640565. DOI: 10.1016/j.bj.2021.02.003.


Bioengineering hemophilia A-specific microvascular grafts for delivery of full-length factor VIII into the bloodstream.

Neumeyer J, Lin R, Wang K, Hong X, Hua T, Croteau S Blood Adv. 2019; 3(24):4166-4176.

PMID: 31851760 PMC: 6929393. DOI: 10.1182/bloodadvances.2019000848.


Expression of RecA and cell-penetrating peptide (CPP) fusion protein in bacteria and in mammalian cells.

Chang X, Hou Y Int J Biochem Mol Biol. 2018; 9(1):1-10.

PMID: 29531845 PMC: 5840312.